Basal cell carcinoma and basal cell nevus syndrome: optimizing treatment and care

Research output: ThesisDoctoral ThesisInternal

456 Downloads (Pure)

Abstract

This study aims to optimize the treatment of basal cell carcinoma and basal cell nevus syndrome. Studies show that surgical excision is more effective than imiquimod 5% cream. Nevertheless, imiquimod 5% cream deserves a place in the treatment of nodular basal cell carcinoma. In addition, treatment of basal cell carcinomas with oral hedgehog signaling pathway inhibitors in patients with basal cell nevus syndrome is highly effective but is often associated with too many side effects to sustain long-term treatment. It is also important to obtain genetic confirmation of the diagnosis of basal cell nevus syndrome because the risk of jaw cysts and medulloblastoma differs for patients with a PTCH1 mutation compared with those with a SUFU mutation.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • Maastricht University
Supervisors/Advisors
  • Mosterd, Klara, Supervisor
  • Reinders, Marieke, Co-Supervisor
  • van Geel, Michel, Co-Supervisor
Award date29 Sept 2023
Place of PublicationMaastricht
Publisher
Print ISBNs9789464831351
DOIs
Publication statusPublished - 2023

Keywords

  • Basal cell nevus syndrome
  • basal cell carcinoma
  • imiquimod
  • hedgehog pathway

Fingerprint

Dive into the research topics of 'Basal cell carcinoma and basal cell nevus syndrome: optimizing treatment and care'. Together they form a unique fingerprint.

Cite this